Bill
H 1092
Overview: H 1092, "An Act to ensure affordable prescription medications through accountability standards", has been accompanied by a new draft, H4489.Purpose and Intent: The primar
Overview: H 1092, "An Act to ensure affordable prescription medications through accountability standards", has been accompanied by a new draft, H4489.
Purpose and Intent: The primary goal of this legislation is to address the issue of high prescription drug prices by establishing new accountability standards and transparency requirements for pharmaceutical manufacturers and other supply chain entities.
Key Provisions:
- Requires drug manufacturers to justify price increases that exceed a certain threshold
- Mandates the disclosure of information related to research and development costs, marketing expenses, and other factors influencing drug pricing
- Empowers the state to take enforcement actions, such as imposing fines or other penalties, against companies that fail to comply with the new accountability standards
Affected Parties and Impacts: This bill would directly impact pharmaceutical manufacturers, as well as other stakeholders in the prescription drug supply chain, including wholesalers, pharmacies, and health plans. Consumers who rely on prescription medications could also potentially benefit from increased transparency and accountability measures aimed at reducing drug prices.
Procedural and Timeline Considerations: The original H 1092 bill has been accompanied by a new draft, H4489, which suggests the legislation is still in the early stages of the legislative process. The next steps would likely involve further committee review, potential amendments, and votes in the full legislature before the final version could be sent to the governor for signature.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
